VALN - Valneva falls as FDA extends review of chikungunya vaccine
2023-08-14 06:42:08 ET
More on Valneva
- Valneva: VLA1553 Takes The Lead In The Chikungunya Vaccine Race
- Valneva COVID shot shelf life extended; gets EMA nod for booster; shows efficacy in trials
- Valneva's single-shot chikungunya vaccine VLA1553 gets FDA priority review
- Seeking Alpha’s Quant Rating on Valneva
- Earnings data for Valneva
For further details see:
Valneva falls as FDA extends review of chikungunya vaccine